ASTCT

Every day, ASTCT members are advancing transplantation and cellular therapy through exceptional patient care, research, education, and service to the field. Help recognize those contributions by submitting a nomination for an ASTCT SIG Award. Award categories include: 🏆 Transplant Infectious Diseases SIG Award • Lifetime Achievement Award 🏆 Nursing SIG Awards • Lifetime Achievement Award • Rising Star Award 🏆 Advanced Practice Provider SIG Awards • Lifetime Achievement Award • Rising Star Award 🏆 Survivorship SIG Awards • Lifetime Achievement Award • Early-Career Achievement Award Nominations close Nov. 9 🔗 ow.ly/AXJk5101lh7

Clinical guidance at your fingertips. Download the ASTCT Practice Guidelines App to access the latest recommendations, review new guidelines and quickly search for information when you need it most. 📱 Learn more: 🔗 ow.ly/fwvH5101lCF

Join experts from around the world at #Tandem27 to explore the latest advances in hematopoietic cell transplantation, cellular therapy, and gene therapy. From cutting-edge clinical research and translational science to emerging therapies and practice-changing innovations, the Tandem Meetings are the premier meetings for #HCT and #CellularTherapy. Register today: 🔗 ow.ly/4rYQ5101lwi

ASTCT Committee Member Spotlight: Yoonhee Choi, MD Meet Yoonhee Choi, MD, a hematology-oncology fellow at the National Cancer Institute and vice chair of ASTCT’s Junior Faculty and Trainee Subcommittee. Hear Dr. Choi discuss her interest in lymphoid malignancies and cellular therapy, the value of getting involved in ASTCT early in your career, and her passion for supporting the next generation of transplant and cellular therapy professionals. Watch the video: ow.ly/jTYG5101kWi

Want to play a more active role in shaping the future of ASTCT? Volunteering is a meaningful way to build your professional network, develop leadership experience, and contribute to initiatives that support the transplantation and cellular therapy community. Explore opportunities to get involved and make an impact. 🔗 ow.ly/O2wV5101ljV

What makes soft tissue sarcoma a promising candidate for TIL therapy? Daniel Olson, MD, John Mullinax, MD, and Lauren Banks, MD discuss the scientific rationale behind tumor-infiltrating lymphocyte (TIL) therapy in sarcoma and why certain subtypes are generating excitement in the field. Hear more in the latest episode of ASTCT Talks. Episode link: ow.ly/HwIp5101kcC

Can't join us for the full ASTCT Gene Therapy Summit? Choose the day that best aligns with your interests and gain insights on ex vivo gene therapy, implementation challenges and emerging innovations alongside leading experts and colleagues. Explore the full schedule and registration options. 🔗 ow.ly/wLrC5101jWk

Planning to attend Tandem Meetings 2027? Travel grants can help make participation possible. Explore available opportunities and apply today to support your journey to one of the field's premier scientific meetings. Apply: ow.ly/Ee8A50ZWRte

We're excited to welcome attendees to the ASTCT Clinical Education Conference. Over the next two days, participants will engage with experts, explore the latest advances in the field and gain practical insights to take back to their practice.

The future of gene therapy is being written now. Be part of the conversation at the ASTCT Gene Therapy Summit, where clinicians, researchers, and innovators come together to discuss breakthrough science, clinical applications, operational challenges, and what's next for the field. Whether you're looking to deepen your expertise or prepare for what's ahead, this is a meeting you won't want to miss. 🔗 Secure your spot today: ow.ly/TeNf50ZShAK

Choosing a conditioning approach means weighing more than intensity alone. How do available RTC approaches compare? What trade-offs should factor into regimen selection? And how can patient- and disease-specific characteristics help guide your decision? Analyze the evidence and strengthen your approach to individualized regimen selection, earning free CE credit along the way: - ow.ly/qZ0W50ZPMUl

Starts tomorrow: Learn from experts, connect with peers and gain practical insights you can apply immediately in your practice. Register today for the ASTCT Clinical Education Conference. Register ow.ly/9eyC50ZWRb2

The field's leading minds. The latest developments. Meaningful connections. Register for Tandem Meetings 2027 and be part of the conversations that are driving the future of transplantation and cellular therapy. ow.ly/yh9H50ZWR6P

Whether you're looking to strengthen your knowledge of established toxicity management strategies or learn about emerging challenges, the ASTCT Toxicities Conference offers education designed to support today's cellular therapy professionals. Register today ow.ly/tzv950ZWR4M

Join colleagues from across the field for the virtual ASTCT Clinical Education Conference on Oct. 22-23, for practical education, expert-led discussions and valuable networking opportunities that support excellence in patient care. ow.ly/wvQp50ZWR2a

During National Pharmacy Week, ASTCT recognizes pharmacists for their expertise, dedication and critical role in advancing transplantation and cellular therapy. Thank you for the impact you make on patients and care teams every day.

The strength of ASTCT comes from members like you — professionals who bring fresh perspectives, share their expertise and help move our field forward. Submit interest to serve on an ASTCT Committee or lead a Special Interest Group (SIG) by Nov. 13. ow.ly/LftC50ZXMe2

Gene therapy is transforming what's possible for patients. Join leading clinicians, researchers and innovators at the ASTCT Gene Therapy Summit for timely education, meaningful discussions and insights into the future of care. ow.ly/JTc050ZWQV3

Can TIL therapy become a new treatment option for patients with sarcoma? In this episode of ASTCT Talks, host Daniel Olson, MD, is joined by John Mullinax, MD, and Lauren Banks, MD, PhD, to discuss the emerging role of tumor-infiltrating lymphocyte (TIL) therapy in sarcoma. The conversation explores early clinical results, patient selection, tumor procurement, and the multidisciplinary collaboration needed to bring this promising cellular therapy approach to patients with solid tumors. 🎧 Listen now: ow.ly/7Tqn50ZWQTc

CAR T-cell therapy has already transformed cancer treatment, but what's next? At the ASTCT Clinical Education Conference, Siddhartha Ganguly, MD, FACP, will examine how CAR T-cell therapy is advancing beyond currently approved indications and what these developments could mean for the future of patient care. Join colleagues from across the field and gain valuable clinical insights you can bring back to your practice. 🔗 Register today: ow.ly/3ix850ZWQRe